Lunesta 80725-0012
Generic: Eszopiclone
Product NDC
80725-0012- Manufacturer
- Waylis Therapeutics Llc
- Dosage Form
- Tablet, Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- August 15, 2023
- Listing Expires
- December 31, 2026
- Application
- NDA021476
Active Ingredients
| Ingredient | Strength |
|---|---|
| Eszopiclone | 3 mg/1 |
Packaging Options(1)
30 TABLET, COATED in 1 BOTTLE (80725-012-30)